Slovakia – Medicinal products for the alimentary tract and metabolism – Medicine with the active substance cerliponase alfa 150 mg, infusion solution
A structured breakdown of scope, eligibility requirements, submission steps, and key conditions — extracted directly from the official notice.
Sign in to unlock Bid Fit & AI Opportunity Intelligence
TenderZenith calculates a personalized qualification score against your company profile and extracts structured intelligence from tender documents with your 7-Day Pro Trial (No Credit Card Required).
Contract Description
The subject of the order is Medicine with the active substance cerliponase alfa 150 mg, infusion solution Pharmaceutical form: sol inf 5 ml/150 mg+5 ml diluted solution (medical injection glass) Administration: intracerebroventricular use The drug cerliponase alfa belongs to a group of drugs known as enzyme replacement therapies. It is used to treat patients with neuronal ceroid lipofuscinosis type 2 (CLN2), also known as tripeptidyl peptidase 1 (TPP1) deficiency. People with CLN2 disease lack or have too little of an enzyme called TPP1, which causes a build-up of substances called